Wambui Machua
Expertise in
21
conditions

Dr. Wambui Machua

Rheumatology
1800 Howell Mill Road, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Expertise in
21
conditions
1800 Howell Mill Road, 
Atlanta, GA 

Overview

Wambui Machua, M.D., completed her residency and fellowship training at Morehouse School of Medicine and Medical College of Georgia respectively. Prior to joining Piedmont, Dr. Machua was previously involved in multiple clinical trials in the Atlanta area. She is a member of the American College of Rheumatology, International Society for Clinical Densitometry and board certified in internal medicine. She serves on the Lupus Foundation of America, Georgia chapter, Medical Advisory Board. Dr. Machua believes medicine brings healing through collaboration between the patient and the medical provider team. She provides compassionate, patient-centered care and utilizes cutting edge therapies and holistic care to manage rheumatic diseases. She is a strong advocate for her patients. In her free time, Dr. Machua enjoys spending time with family and friends, walking and cooking. Dr. Machua welcomes new patients and accepts most insurance plans.

Dr. Machua is highly rated in 21 conditions, according to our data. Her top areas of expertise are Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Lupus Nephritis, and Cutaneous Lupus Erythematosus (CLE).

Her clinical research consists of co-authoring 6 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

American University Of Integrative Sciences/ University Of Sint Eustatius, 2008

Residency

Morehouse School of Medicine, Internal Medicine, 2013

Specialties

Rheumatology

Licenses

Internal Medicine in GA

Board Certifications

American Board Of Internal Medicine
American Board Of Internal Medicine - Rheumatology

Fellowships

Augusta University (formerly Georgia Regents Medical Center), Rheumatology, 2015

Hospital Affiliations

Piedmont Hospital, Inc

Languages Spoken

English
Kiswahili

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Piedmont Physicians Rheumatology Atlanta
1800 Howell Mill Road, Atlanta, GA 30318

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 5 Less Clinical Trials

6 Total Publications

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development.
A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development.
Journal: Arthritis care & research
Published: June 26, 2025
Similar Doctors
Arezou Khosroshahi
Expertise in
13
conditions
Dr. Arezou Khosroshahi
Rheumatology
Expertise in
13
conditions
Dr. Arezou Khosroshahi
Rheumatology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
 (4.0 miles away)
404-778-4366
Experience:
25+ years
Languages Spoken:
English, Farsi
See accepted insurances
Offers Telehealth

Arezou Khosroshahi is a Rheumatologist in Atlanta, Georgia. Dr. Khosroshahi has been practicing medicine for over 25 years is highly rated in 13 conditions, according to our data. Her top areas of expertise are IgG4-Related Disease, Lupus Nephritis, MAGIC Syndrome, and Light Chain Deposition Disease (LCDD).

Expertise in
51
conditions
Dr. Mala Kaul
Rheumatology
Expertise in
51
conditions
Dr. Mala Kaul
Rheumatology

Jenkins Clinic Inc.

1800 Howell Mill Rd NW Ste 500, 
Atlanta, GA 
 (1.3 miles away)
404-367-3350
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mala Kaul is a Rheumatologist in Atlanta, Georgia. Dr. Kaul is highly rated in 51 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, IgG4-Related Disease, and Light Chain Deposition Disease (LCDD).

Jonathan Waltuck
Expertise in
30
conditions
Dr. Jonathan Waltuck
Rheumatology
Expertise in
30
conditions
Dr. Jonathan Waltuck
Rheumatology

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgA, 
Atlanta, GA 
 (4.0 miles away)
404-778-4366
Experience:
40+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Waltuck is a Rheumatologist in Atlanta, Georgia. Dr. Waltuck has been practicing medicine for over 40 years is highly rated in 30 conditions, according to our data. His top areas of expertise are Lupus Nephritis, Rheumatoid Arthritis (RA), Necrotizing Vasculitis, and Dermatomyositis.

Frequently Asked Questions about Dr. Wambui Machua

How do I make an appointment with Dr. Wambui Machua?

You can book an appointment with Dr. Wambui Machua by calling their office at 404-367-3350. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Wambui Machua a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Wambui Machua is classified as an Distinguished expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Wambui Machua specialize in?

While Dr. Wambui Machua is a Rheumatology, they have specific expertise in Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Lupus Nephritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Wambui Machua participate in research or clinical trials?

Yes. Dr. Wambui Machua has published 6 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Dr. Wambui Machua's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Wambui Machua accept my insurance?

Dr. Wambui Machua accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 404-367-3350 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Machua's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile